Evidence map›Paper›PMID 37901318›Full record

ArticleFrontiers in oncology2023

A radiomics nomogram for predicting postoperative recurrence in esophageal squamous cell carcinoma.

Yahan Tong, Junyi Chen, Jingjing Sun, Taobo Luo, Shaofeng Duan, Kai Li, Kefeng Zhou, Jian Zeng, Fangxiao Lu

Abstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yahan TongDepartment of Radiology, Zhejiang Cancer Hospital, Hangzhou, China.
Junyi ChenMedical School of Chinese People's Liberation Army (PLA), Beijing, China.
Jingjing SunDepartment of Radiology, Zhejiang Cancer Hospital, Hangzhou, China.
Taobo LuoDepartment of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
Shaofeng DuanGE Healthcare, Precision Health Institution, Shanghai, China.
Kai LiDepartment of Radiology, Zhejiang Cancer Hospital, Hangzhou, China.
Kefeng ZhouDepartment of Radiology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Jian ZengDepartment of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
Fangxiao LuDepartment of Radiology, Zhejiang Cancer Hospital, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To establish and validate a radiomics nomogram for predicting recurrence of esophageal squamous cell carcinoma (ESCC) after esophagectomy with curative intent. Materials and methods: The medical records of 155 patients who underwent surgical treatment for pathologically confirmed ESCC were collected. Patients were randomly divided into a training group (n=109) and a validation group (n=46) in a 7:3 ratio. ​Tumor regions are accurately segmented in computed tomography images of enrolled patients. Radiomic features were then extracted from the segmented tumors. We selected the features by Max-relevance and min-redundancy (mRMR) and least absolute shrinkage and selection operator (LASSO) methods. A radiomics signature was then built by logistic regression analysis. To improve predictive performance, a radiomics nomogram that incorporated the radiomics signature and independent clinical predictors was built. Model performance was evaluated by receiver operating characteristic (ROC) curve, calibration curve, and decision curve analyses (DCA). Results: We selected the five most relevant radiomics features to construct the radiomics signature. The radiomics model had general discrimination ability with an area under the ROC curve (AUC) of 0.79 in the training set that was verified by an AUC of 0.76 in the validation set. The radiomics nomogram consisted of the radiomics signature, and N stage showed excellent predictive performance in the training and validation sets with AUCs of 0.85 and 0.83, respectively. Furthermore, calibration curves and the DCA analysis demonstrated good fit and clinical utility of the radiomics nomogram. Conclusion: We successfully established and validated a prediction model that combined radiomics features and N stage, which can be used to predict four-year recurrence risk in patients with ESCC who undergo surgery.

Indexed as

esophageal squamous cell carcinoma/esophageal cancernomogramradiomicsrecurrencetomographyX-Ray Computed

Identifiers

PMID37901318
PMCPMC10602760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.